Tempus AI TEM
Tempus AI, Inc. · Nasdaq · Services-Computer Programming, Data Processing, Etc.
$76.61+6.18%close on Oct. 28, 2026 · volume 6.9M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Sept. 25, 2026 | Thomas Edward Schoenherr CEO, Diagnostics | Sold 10b5-1 plan | 10,281 | $85.00 | $873,885 |
| Sept. 22, 2026 | Eric P. Lefkofsky CEO and Chairman, director, 10% owner · indirect | Sold 10b5-1 plan | 250,000 | $77.47 $76.57-$78.86 | $19.37 million |
| Sept. 17, 2026 | Eric P. Lefkofsky CEO and Chairman, director, 10% owner · indirect | Sold 10b5-1 plan | 200,000 | $80.57 $80.52-$81.09 | $16.11 million |
| Sept. 17, 2026 | Ryan M. Bartolucci Chief Accounting Officer | Sold 10b5-1 plan | 7,062 | $75.00 | $529,650 |
| Sept. 17, 2026 | Andrew Polovin EVP, Chief Legal Officer | Sold 10b5-1 plan | 2,951 | $75.00 | $221,325 |
| Sept. 16, 2026 | Ryan Fukushima CEO, Data · indirect | Sold 10b5-1 plan | 700 | $70.00 | $49,000 |
| Sept. 1, 2026 | Ryan Fukushima CEO, Data · indirect | Sold 10b5-1 plan | 30,846 | $62.71 $62.12-$64.63 | $1.93 million |
| Sept. 1, 2026 | Jennifer A. Doudna director | Sold 10b5-1 plan | 676 | $65.55 | $44,312 |
| Sept. 1, 2026 | David R. Epstein director | Sold 10b5-1 plan | 250 | $65.55 | $16,388 |
| Aug. 28, 2026 | Nadja West director | Sold 10b5-1 plan | 3,000 | $69.00 | $207,000 |
| Aug. 25, 2026 | Eric P. Lefkofsky CEO and Chairman, director, 10% owner · indirect | Sold 10b5-1 plan | 11,848 | $69.87 $69.83-$70.58 | $827,857 |
| Aug. 25, 2026 | Eric P. Lefkofsky CEO and Chairman, director, 10% owner · indirect | Sold 10b5-1 plan | 238,152 | $68.39 $64.03-$70.58 | $16.29 million |
Latest 12 of 28. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 32 →Other events
AI summary, unreviewedTempus AI Signs $192.5 Million in Data Licensing Agreements with Bristol-Myers Squibb and Pathos AI